216 related articles for article (PubMed ID: 9632718)
21. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
22. The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family.
Johnson JP; Rothbächer U; Sers C
Melanoma Res; 1993 Oct; 3(5):337-40. PubMed ID: 8292890
[TBL] [Abstract][Full Text] [Related]
23. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
25. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
26. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
Melnikova VO; Balasubramanian K; Villares GJ; Dobroff AS; Zigler M; Wang H; Petersson F; Price JE; Schroit A; Prieto VG; Hung MC; Bar-Eli M
J Biol Chem; 2009 Oct; 284(42):28845-55. PubMed ID: 19703903
[TBL] [Abstract][Full Text] [Related]
28. Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains.
Sers C; Kirsch K; Rothbächer U; Riethmüller G; Johnson JP
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8514-8. PubMed ID: 8378324
[TBL] [Abstract][Full Text] [Related]
29. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
Rummel MM; Sers C; Johnson JP
Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
[TBL] [Abstract][Full Text] [Related]
30. Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
Tellez C; Bar-Eli M
Oncogene; 2003 May; 22(20):3130-7. PubMed ID: 12789289
[TBL] [Abstract][Full Text] [Related]
31. Regulation of gene expression in melanoma: new approaches for treatment.
Leslie MC; Bar-Eli M
J Cell Biochem; 2005 Jan; 94(1):25-38. PubMed ID: 15523674
[TBL] [Abstract][Full Text] [Related]
32. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability.
Yang H; Wang S; Liu Z; Wu MH; McAlpine B; Ansel J; Armstrong C; Wu G
Gene; 2001 Mar; 265(1-2):133-45. PubMed ID: 11255016
[TBL] [Abstract][Full Text] [Related]
34. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
35. Cellular adhesion pathways and metastatic potential of human melanoma.
McGary EC; Lev DC; Bar-Eli M
Cancer Biol Ther; 2002; 1(5):459-65. PubMed ID: 12496470
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.
Braeuer RR; Zigler M; Villares GJ; Dobroff AS; Bar-Eli M
Semin Cancer Biol; 2011 Apr; 21(2):83-8. PubMed ID: 21147226
[TBL] [Abstract][Full Text] [Related]
37. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.
Lehmann JM; Riethmüller G; Johnson JP
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381
[TBL] [Abstract][Full Text] [Related]
38. Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS.
Schwarz MJ; Müller N; Körschenhausen D; Kirsch KH; Penning R; Ackenheil M; Johnson JP; Hampel H
Neuroimmunomodulation; 1998; 5(5):270-6. PubMed ID: 9730695
[TBL] [Abstract][Full Text] [Related]
39. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
Shih IM; Elder DE; Hsu MY; Herlyn M
Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
